FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377201003: Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3676820017 Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676821018 Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676823015 Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202517018 Aspirin + caffeine + propoxyphene hydrochloride 389mg/32.4mg/65mg capsule (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215428019 Aspirin + caffeine + propoxyphene hydrochloride 389mg/32.4mg/65mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478577013 Aspirin+caffeine+propoxyphene hydrochloride 389mg/32.4mg/65mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3490401015 Product containing aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg/1 each oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494179016 Product containing aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494180018 Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569139011 Product containing only aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569140013 Product containing only aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg/1 each oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676820017 Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676821018 Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676822013 Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676823015 Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Product containing caffeine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Aspirin compound preparation (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Dextropropoxyphene (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Oral caffeine (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bronchodilator false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opiate agonist (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Stimulant (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextropropoxyphene false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opioid receptor agonist false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Product containing aspirin and caffeine and propoxyphene hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphodiesterase inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has manufactured dose form A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Oral aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Oral caffeine (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has manufactured dose form Oral capsule true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value 389 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value Arabic numeral 65 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value 32.4 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value Arabic numeral 65 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value 389 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Caffeine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has presentation strength numerator value 32.4 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Product containing aspirin and caffeine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has precise active ingredient Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has unit of presentation Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has precise active ingredient Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has precise active ingredient Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Is a Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has precise active ingredient Caffeine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has precise active ingredient Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Has basis of strength substance (attribute) Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start